Scarica l'app Stockscreener
0.277
4.48%
-0.013
Dopo l'orario di chiusura:
.29
0.013
+4.69%
Precedente Chiudi:
$0.29
Aprire:
$0.29
Volume 24 ore:
676.77K
Relative Volume:
0.07
Capitalizzazione di mercato:
$7.06M
Reddito:
$357.90K
Utile/perdita netta:
$-11.06M
Rapporto P/E:
-0.2473
EPS:
-1.1201
Flusso di cassa netto:
$-11.90M
1 W Prestazione:
-13.98%
1M Prestazione:
-25.05%
6M Prestazione:
-74.82%
1 anno Prestazione:
-82.90%
Intervallo 1D:
$0.2698
$0.3124
Intervallo di 1 settimana:
$0.2698
$0.346
Portata 52W:
$0.1593
$1.89
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Nome
Biorestorative Therapies Inc
Settore
Industria
Telefono
(631) 760-8100
Indirizzo
40 MARCUS DRIVE, MELVILLE
Compare BRTX vs VRTX, REGN, ARGX, RVMD, ALNY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
0.277 | 7.39M | 357.90K | -11.06M | -11.90M | -1.1201 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Biorestorative Therapies Inc Borsa (BRTX) Ultime notizie
BioRestorative Therapies Inc (BRTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioRestorative Therapies Inc (BRTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BRTX|BioRestorative Therapies Inc|Price:0.290|Chg%:-0.022 - TradingKey
TradingKey - TradingKey
BioRestorative Therapies Inc (BRTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioRestorative Therapies, Inc. Revenue Breakdown – GETTEX:9OF - TradingView
Biorestorative Therapies Company Profile & Introduction - Moomoo
BioRestorative Therapies Inc (BRTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioRestorative Therapies (BRTX) Q1 2026 Earnings: Narrower Loss Beats Estimates as Company Advances PipelineAnnual Financial Report - dars.gov.et
BioRestorative Therapies Announces Amendments to Executive Employment Agreements in July 2026 - Minichart
Leadership shake-up at Biorestorative Therapies (NASDAQ: BRTX) and new CEO - Stock Titan
BioRestorative Therapies, Inc. Announces CFO Changes, Effective July 13, 2026 - marketscreener.com
BioRestorative Therapies (BRTX) Bounces from Support, Stages 3.5% RecoveryOBV Divergence - dars.gov.et
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX) - AOL.com
Price to book forward of BioRestorative Therapies, Inc. – GETTEX:9OF - TradingView
BioRestorative Therapies (BRTX) Slides 1% to $0.40, Tests Key Support Amid Low VolumeWyckoff Upthrust - dars.gov.et
BRTX Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Cost Discipline Amid Clinical Progress - dars.gov.et
Here's why Biorestorative Therapies (BRTX) looks ripe for bottom fishing - MSN
BioRestorative Therapies, Inc.'s Equity Buyback announced on August 12, 2025, has expired. - marketscreener.com
BioRestorative Therapies (BRTX) Rises 1.62% as Stock Holds Above Key Support at $0.36Volatility Stop - DonanımHaber
Enterprise value to EBITDA forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX - TradingView
Price to earnings forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX - TradingView
Price to earnings forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF - TradingView
BioRestorative (NASDAQ:BRTX) Gains Penny Stock Attention - Kalkine Media
Enterprise value to revenue forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX - TradingView
Enterprise value to revenue forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF - TradingView
Price to book forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX - TradingView
Price to sales forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF - TradingView
Price to book forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF - TradingView
BioRestorative Therapies, Inc. Actuals & Estimates (NASDAQ:BRTX) - TradingView
BRTX Forecast — Price Target — Prediction for 2027 - TradingView
BioRestorative Therapies, Inc. Actuals & Estimates (DUS:9OF) - TradingView
9OF Forecast — Price Target — Prediction for 2027 - TradingView
A3C9XF Forecast — Price Target — Prediction for 2027 - TradingView
BioRestorative Therapies Announces Completion of BRTX-100 Manufacturing for Phase 2 Clinical Trial - Moomoo
BioRestorative finishes BRTX-100 Phase 2 supply in-house - Stock Titan
BioRestorative Therapies Inc (BRTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BRTX Q1 2026 Earnings: Narrowed Loss Per Share Beats Estimates, Stock RisesEarnings Analysis - dars.gov.et
BRTX News | BIORESTORATIVE THERAPIES INC (NASDAQ:BRTX) - ChartMill
Director Mika Grasso files initial Form 3 at BioRestorative (BRTX) - Stock Titan
BioRestorative Therapies (NASDAQ: BRTX) director Dhaliwal files clean Form 3 - Stock Titan
BioRestorative Therapies Inc (BRTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth - The Manila Times
BioRestorative Therapies Appoints Zachary Smith as Vice President of Biocosmeceuticals Division - Quiver Quantitative
BioRestorative Therapies Inc (BRTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioRestorative Therapies Inc (BRTX) Institutional Confidence - TradingKey
BioRestorative Therapies (BRTX) director Katharyn Field files initial Form 3 - Stock Titan
BioRestorative Therapies Inc - TradingKey
Discontinued operations of BioRestorative Therapies, Inc. – DUS:9OF - TradingView
Long term debt to total equity ratio of BioRestorative Therapies, Inc. – DUS:9OF - TradingView
Biorestorative Therapies Inc Azioni (BRTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):